Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
UPDATE: Cantor Fitzgerald Starts Spring Bank Pharmaceuticals (SBPH) at Overweight
-
NextDecade Signs MOU with Port of Cork to Develop FSRU and LNG Import Terminal Infrastructure
-
CymaBay Therapeutics (CBAY) Prices 13M Common Stock Offering at $6.50/Share
-
CymaBay Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Remains Bullish on UnitedHealth Group (UNH) Following 2Q Release
-
IBM (IBM): Strategic Imperatives Slow, Cutting PT - Cantor
-
Arena Pharma (ARNA): Ralinepag PhII Proves Market Extends Beyond PAH - Cantor
-
UPDATE: Netflix (NFLX) PT Raised to $205 at Cantor Fitzgerald
-
BGC Partners (BGCP) Reports Acquisition of Berkeley Point Financial LLC for $875M from Cantor Fitzgerald Affiliate, L.P.2
-
BGC Partners Agrees to Acquire 100 Percent of Berkeley Point Financial LLC
-
ELS Reports Second Quarter Results
-
CymaBay Therapeutics (CBAY) Announces 10M Share Common Offering
-
CymaBay Announces Proposed Public Offering of Common Stock
-
Corbus Pharma (CRBP): Notes From KOL Call - Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Lantheus Holdings (LNTH) at Overweight
-
Health Insurance Innovations (HIIQ) PT Raised to $35 at Cantor Fitzgerald
-
Netflix, Inc. (NFLX): Expect Solid Results - Cantor
-
Arena Pharma (ARNA) Prices 6.25M Share Offering at $24/Sh
-
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Quinpario, SourceHOV and Novitex Complete Business Combination and Launch Exela Technologies, Inc.
-
Orchid Island Capital Announces July 2017 Monthly Dividend and June 30, 2017 RMBS Portfolio Characteristics
-
Exela Technologies, Inc., a Publicly Traded Company, Completes Business Combination with SourceHOV and Novitex
-
PlacementTracker Publishes First Half 2017 PIPE Market League Tables
-
Oclaro (OCLR) PT Lowered to $21 at Cantor Fitzgerald on 'Delays from CRL, but Maintain Confidence'
-
UPDATE: Cantor Fitzgerald Starts Progenics Pharmaceuticals (PGNX) at Overweight
-
Arena Pharma (ARNA) Announces $150M Common Offering
-
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Egalet Announces Closing of $30 Million Public Equity Offering
-
UPDATE: Cantor Fitzgerald Starts Great Lakes Dredge & Dock (GLDD) at Buy
-
BTIG Expands Healthcare Equity Research with Life Science and Diagnostic Tools Analyst Sung Ji Nam
-
Integra LifeSciences (IART): Cadence Could Be The Cornerstone Of A New Market - Cantor Fitzgerald
-
Advaxis (ADXS): CEO Departure A Surprise But Does Not Change The Story - Cantor
-
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2017
-
Harmony Files Definitive Proxy Statement, Schedules Stockholder Vote on NextDecade Merger for July 24
-
Egalet (EGLT) Prices 16.7M Shares Offering at $1.80, Including Warrants
-
Egalet Announces Pricing of Public Offering of Common Stock and Warrants
-
Prometic announces closing of equity offerings for aggregate gross proceeds of $61.7 million
-
Cantor Fitzgerald Starts GenOn Energy (GEN) at Overweight
-
Egalet (EGLT) Announces Public Offering
-
Egalet Announces Proposed Public Offering of Common Stock and Warrants
-
Supernus Pharmaceuticals (SUPN) PT Raised to $49 at Cantor Fitzgerald
-
HealthEquity, Inc (HQY) PT Raised to $56 at Cantor Fitzgerald, "Management Meetings Confirm Positive Growth Outlook"
-
Easterly Acquisition Corp (EACQ) to Merge with JH Capital Group Holdings
-
JH Capital Group Holdings, LLC to Become Public Company Through a Combination with Easterly Acquisition Corp.
-
Cantor Fitzgerald Issues New Coverage On 9 Medical Equipment Names
-
Arena Pharma (ARNA): Ralinepag XR Shows Early Signs of Life - Cantor
-
Cantor Fitzgerald Starts Zimmer Biomet (ZBH) at Neutral
-
Cantor Fitzgerald Starts Wright Medical (WMGI) at Overweight
-
Cantor Fitzgerald Starts ViewRay Inc. (VRAY) at Overweight
-
Cantor Fitzgerald Starts Stryker (SYK) at Neutral

